logo

For the Inventor, By the Inventor

Strasbourg, France

Abdesslame Nazih

This inventor holds 4 USPTO granted patents. Top assignee: Transgene S.a.. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdesslame Nazih. Retrieved from https://idiyas.com/inventor/abdesslame-nazih

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 75.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 116(Granted Patents)


Company Filing History:

goldMedal4 out of 159 
 
Transgene S.a.
 patents

Years Active: 2001-2004

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6743781 - Glycerolipid compounds useful for the transfer of an active substance into a target cell (2004-06-01),
2. 6335199 - Lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use (2002-01-01),
3. 6291423 - Lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy (2001-09-18),
4. 6218370 - Glycerolipidic compounds used for the transfer of an active substance into a target cell (2001-04-17),

Title: Abdesslame Nazih: Innovator in Lipid Compounds and Gene Therapy

Introduction

Abdesslame Nazih is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of lipid compounds and gene therapy, holding a total of 4 patents. His work focuses on the development of innovative compounds that facilitate the transfer of active substances into target cells.

Latest Patents

Among his latest patents, Abdesslame Nazih has developed glycerolipid compounds that are useful for the transfer of active substances into target cells. One of his notable inventions includes lipid compounds and compositions that are utilized for the transfer of polynucleotides into target cells for therapeutic purposes. These lipid compounds are characterized by a specific formula and may exist in a cationic form, often combined with biologically acceptable anions. His inventions also encompass complexes that consist of cationic lipid compounds and negatively charged active substances, along with methods of gene therapy that utilize these complexes.

Career Highlights

Throughout his career, Abdesslame Nazih has worked with various companies, including Transgene S.A. and Transgene 6.A. His expertise in lipid compounds has positioned him as a key figure in the advancement of gene therapy technologies.

Collaborations

Abdesslame Nazih has collaborated with notable professionals in his field, including Rainer Bischoff and Denis Heissler. These collaborations have further enriched his research and development efforts.

Conclusion

Abdesslame Nazih's innovative work in lipid compounds and gene therapy has made a significant impact in the scientific community. His patents reflect a commitment to advancing therapeutic methods and improving the transfer of active substances into target cells.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…